著者 Maksym Misichenko · Yahoo Finance ·
AIエージェントがこのニュースについて考えること
Salesforce's transition to AI-driven Agentforce faces execution risks, with potential margin pressure from increased R&D spend and uncertainty around net-new bookings. The consensus is mixed, with concerns about AI disruption and margin risk outweighing optimism about core business resilience and AI's long-term potential.
リスク: Margin pressure from ramping AI R&D spend and uncertainty around net-new bookings from Agentforce
機会: Potential for AI-augmented CRM to unlock new revenue streams if adoption accelerates
本分析は StockScreener パイプラインで生成されます — 4 つの主要な LLM（Claude、GPT、Gemini、Grok）が同じプロンプトを受け取り、組み込みの幻覚防止ガードが備わっています。 方法論を読む →
ジャビ・バブ著
5月27日（ロイター） - Salesforceは水曜日、AI主導の混乱が従来のソフトウェア需要を覆い、第一四半期の予想を上回る業績を打ち消したため、第二四半期の売上高をウォール街の予想を下回る水準と予測しました。
ビジネスソフトウェアプロバイダーの株は、不安定な時間外取引でわずかに下落しました。年初以来、約33%下落しており、2025年には20%以上下落しています。
Salesforceも、その同業者と同様に、急速に進化するAIツールが、従来のソフトウェアから企業クライアントを引き離し、かつて自社製品が行っていたタスクを引き継ぐことで、投資家の懸念が高まっているという問題に直面しています。
AnthropicやOpenAIによる高度なコーディングツールは、ソフトウェア株の最近の売却に寄与し、ウォールストリートが「SaaSpocalypse」と呼んでいる状況を引き起こしました。これは、ソフトウェア as a service企業を取り巻く不吉な状況を反映する用語です。
Salesforceは、LSEGがコンパイルしたデータによると、アナリストの平均予想である113億6000万ドルを下回る、112億7000万ドルから113億5000万ドルの間で第二四半期の売上高を見込んでいます。
業界アナリスト企業ValoirのCEOであるレベッカ・ウェッテマンは、「今後数四半期はSalesforceにとって重要であり、コア顧客が席あたりのライセンスから得られる価値、およびAgentforce顧客がAIから得られる価値を示す必要がある」と述べました。
Salesforceは、Agentforce自律エージェントプラットフォームを通じて、AIエージェント企業としての再発明を試みています。これは依然として小規模なビジネスです。
同社は第一四半期に調整後1株当たり利益3.88ドルを報告し、3.12ドルの予想を上回りました。
Salesforceは、4月30日に終了した四半期に111億3000万ドルの売上高を報告し、110億5000万ドルの予想を上回りました。これは、AI搭載のビジネスソフトウェアの強力な採用によって支えられています。
CEOのマーク・ベニオフは、四半期末の通話で、四半期に100万ドルを超える年間契約価値を持つ98件の新規取引を締結したと述べました。
四半期ごとのサブスクリプションおよびサポート収入は14%増加し、これも予想を上回りました。
（メキシコシティからジャビ・バブが報告。シルピ・マジュムダールが編集）
4つの主要AIモデルがこの記事を議論
"CRM's weak Q2 guidance signals AI disruption risks to legacy SaaS outweigh the Q1 beat and early Agentforce traction."
Salesforce's Q2 revenue guidance of $11.27-11.35B, below the $11.36B consensus, underscores execution risk in its Agentforce pivot even after a solid Q1 beat of $11.13B revenue and $3.88 adjusted EPS. The 33% YTD decline and 'SaaSpocalypse' selloff reflect real pressure on per-seat licensing as Anthropic/OpenAI tools erode enterprise demand. With 98 new $1M+ deals still tied mostly to legacy subscriptions, the next two quarters will test whether AI agents can scale fast enough to protect 14% subscription growth. This setup favors caution on multiples until monetization proof emerges.
Agentforce could still ramp faster than modeled if early customers expand usage aggressively, converting the current small business into a material offset before core license erosion accelerates.
"Salesforce's Q2 guide is a non-event (1–2% below consensus), but the stock's 33% YTD decline has priced in existential AI risk that one quarter of resilience won't resolve—the real test is whether Agentforce revenue acceleration appears by late 2025."
The headline is misleading. Q1 beat on both revenue ($11.13B vs $11.05B est.) and especially EPS ($3.88 vs $3.12 est.—24% beat). The Q2 guide of $11.27–$11.35B is only 1–2% below consensus $11.36B—a rounding error, not a miss. What's actually happening: Salesforce is guiding conservatively while Agentforce (AI agents) remains pre-scale. The 98 $1M+ deals and 14% subscription growth suggest core business resilience. The 'SaaSpocalypse' framing is market psychology, not Salesforce-specific deterioration. The real risk isn't AI disruption this quarter—it's whether Agentforce can meaningfully move the needle by 2026.
If AI agents truly commoditize CRM workflows, Salesforce's per-seat licensing model faces structural headwinds that one strong quarter doesn't disprove; the company may be guiding low to manage expectations while Agentforce adoption remains negligible relative to core revenue.
"Salesforce faces a structural shift where the market is discounting the stock for potential AI-driven cannibalization of its core seat-based licensing model."
Salesforce (CRM) is trapped in a valuation transition. While the Q1 beat on EPS ($3.88 vs $3.12) and subscription growth (14%) shows the core business is resilient, the market is aggressively de-rating SaaS multiples due to the 'SaaSpocalypse' narrative. The revenue miss for Q2 guidance, however small, signals that AI-driven efficiency gains might be cannibalizing seat-based pricing models. Investors are no longer paying for legacy growth; they are demanding proof that Agentforce can offset the potential decline in traditional per-seat license revenue. Until Salesforce demonstrates that autonomous agents generate higher-margin, durable revenue than the legacy model, the stock will likely remain range-bound or under pressure despite the strong fundamental performance.
The 'SaaSpocalypse' narrative may be an overreaction; if Agentforce successfully captures the enterprise AI workflow, Salesforce could see a massive expansion in contract value that more than compensates for any erosion in traditional seat-based licensing.
"Salesforce's AI-enabled monetization path (Agentforce and embedded AI) can drive higher ARR and pricing power, offsetting near-term demand softness."
Salesforce walks a fine line: the near-term guidance miss looks like a classic growth stock pause amid AI hype, but the underlying metrics show healthy demand—Q1 revenue beat, 14% subscription growth, and 98 deals over $1M ACV signal stickiness and potential for cross-sell into AI-enabled workflows. The biggest blind spot in the article is assuming AI disruption equals doom for CRM licenses. Enterprise buyers likely want AI-augmented CRM, not a full replacement, and Salesforce’s Agentforce may unlock new revenue streams if adoption accelerates. The risk lies in execution and gross margins while AI investments scale.
AI disruption could pressure demand for traditional CRM licenses, and Salesforce still must prove Agentforce can scale; the modest 2Q miss and deteriorating multiple suggest the market is not convinced yet.
"The modest miss plus legacy deal reliance signals transition friction and unmentioned margin risks from AI spend."
Claude dismisses the Q2 guide as a rounding error, but combined with the 98 deals still legacy-tied, it highlights execution risk in scaling Agentforce fast enough to offset per-seat erosion. No one flagged the margin pressure from ramping AI R&D spend while subscription growth slows to 14%. If investments outpace monetization through 2025, the EPS beat could prove fleeting despite resilient core metrics.
"Margin trajectory on Agentforce deals versus legacy subscriptions is the missing data point that determines whether AI investments are accretive or dilutive to EPS growth."
Grok raises a legitimate margin squeeze that everyone sidestepped. But the 14% subscription growth isn't slowing—it's stable YoY. The real question: what's the gross margin trend on Agentforce deals versus legacy? If new AI deals carry 75%+ margins versus 80%+ on seats, that's a headwind. If they're 85%+, the mix-shift actually improves profitability. The article doesn't disclose this. Without it, we're debating blind.
"Decelerating RPO growth suggests the 14% subscription growth is a lagging indicator that masks fundamental demand erosion."
Claude is right about the margin mix, but we are ignoring the elephant in the room: Salesforce's RPO (Remaining Performance Obligation). If subscription growth is 'stable' at 14% but RPO growth is decelerating, the pipeline is drying up. Grok’s focus on the Q2 guide isn't just about 'rounding errors'; it’s about the lack of visibility into whether Agentforce is actually driving net-new bookings or just cannibalizing existing renewals. That is the real valuation trap.
"Agentforce’s margin trajectory is the key risk; without durable, high-margin AI revenue, Salesforce faces ongoing multiple compression even with steady subscription growth."
Margin risk from AI investment is underappreciated here. The 14% subscription growth and 98 >$1M deals may mask that Agentforce ramp requires upfront R&D and could carry lower gross margins than legacy seats. If AI-driven deals stay margin-light for longer, gross margin and FCF pressure could persist even as core revenue holds. Until the AI mix proves durable, multiple compression seems likely, not a near-term rebound.
Salesforce's transition to AI-driven Agentforce faces execution risks, with potential margin pressure from increased R&D spend and uncertainty around net-new bookings. The consensus is mixed, with concerns about AI disruption and margin risk outweighing optimism about core business resilience and AI's long-term potential.
Potential for AI-augmented CRM to unlock new revenue streams if adoption accelerates
Margin pressure from ramping AI R&D spend and uncertainty around net-new bookings from Agentforce